Dutch agency suspends marketing of all escitalopram-containing generics
This article was originally published in SRA
Executive Summary
The Dutch Medicines Evaluation Board has suspended the marketing authorisation of several drugs containing the generic version of Lundbeck’s antidepressant drug, Lexapro (escitalopram). The suspension will remain in place until April 2010 at the latest1.